SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing intense speculation and polarized debate as investors brace for upcoming earnings, with the community closely tracking indicators of AI-driven commercial demand and sovereign contract growth. Market participants are split between bullish sentiment fueled by potential revenue acceleration and skeptical outlooks regarding the stock's premium valuation and the sustainability of its AI-related expansion.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a private exchange of debt for equity, a move that has sparked intense debate among investors regarding the balance between long-term debt reduction and immediate shareholder dilution. The community remains deeply divided, with some viewing the move as a strategic cleanup of the balance sheet ahead of potential acquisitions, while others express frustration over the impact on share price and management's capital allocation decisions.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors weigh heavy skepticism toward its leadership and share structure against speculative optimism surrounding upcoming AI/AR smart glasses and potential monetization improvements. While the community remains deeply divided over the CEOs management and persistent lawsuits, the stock is seeing significant options activity and bullish speculation ahead of its next earnings release.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is surging following a 10-3 vote from an FDA advisory committee that deemed its lead melanoma drug's efficacy results clinically meaningful, despite prior regulatory setbacks. The community is heavily focused on the impending PDUFA decision while debating whether the positive panel outcome is enough to overcome previous data concerns or if it remains a risky setup for a potential third rejection.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant selling pressure and volatility as traders weigh negative sentiment regarding margin pressure against strong underlying growth and acquisition-driven expansion. The community is sharply divided, with bulls viewing the current price as a generational buying opportunity ahead of upcoming earnings, while skeptics point to intense market competition and technical weakness as reasons to remain cautious.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors intensely monitor the anticipated 80th event data release and potential buyout rumors, fueling a clash between long-term bulls and skeptical short-sellers. Community discussion is focused on the impact of a possible quiet period and the looming top-line Phase 3 trial results, which many view as a critical catalyst for the stock's future valuation.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are actively debating Luckin Coffee's long-term growth potential and store expansion strategy in the U.S. and China, while closely monitoring upcoming earnings reports for catalysts that could trigger a price breakout. Sentiment remains polarized between long-term holders confident in the company's fundamentals and those concerned about market volatility, OTC listing status, and the ongoing competitive landscape.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a significant sell-off following an earnings release that, while beating revenue expectations and raising full-year guidance, resulted in an EPS miss driven by reinvestment in clinical pipeline growth. Shareholders are currently debating whether the sharp price decline represents a manufactured short attack or a standard market reaction to earnings-related volatility, with many long-term investors highlighting strong commercial execution and the potential for a future acquisition as reasons to maintain their positions.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense volatility as the community remains deeply divided over its status as a defensive value play versus a fundamentally broken brand, with high-conviction bears aggressively shorting the stock ahead of upcoming earnings. Traders are closely monitoring the stock's struggle to hold key support levels, with heated debates centered on whether menu pricing, consumer slowdowns, and potential health-related supply chain concerns justify a deeper sell-off.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is trending as investors digest news of successful bond offerings and ongoing fundraising activity, which the community sees as a rebuttal to bearish private credit narratives and liquidity concerns. Despite persistent volatility and negative media sentiment regarding redemption pressures, many investors are focused on the firm's long-term growth in data center infrastructure and underlying portfolio stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Illumina, Inc. (ILMN) Hits Fresh High: Is There Still Room to Run?

Illumina (ILMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

NeoGenomics Reports Second Quarter 2026 Results

NeoGenomics, Inc. (NASDAQ: NEO) (the Company), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its second-quarter results for the period ended June 30, 2026. Financial Highlights For the three-month period ended June 30, 2026, as compared to the...

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

NeoGenomics, Inc. (the Company) (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it has finalized a civil settlement with the Department of Justice (DOJ) on behalf of the Office of Inspector General of the U.S. Department of...

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) for patients with...

Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?

Precision BioSciences (DTIL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S. financial markets on Tuesday, July 28, 2026. Company management will host a...

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of Carolyn Starrett to its Board of Directors. Ms. Starrett brings over 25 years of commercial, product, and operations experience at data and...

NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?

NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of $275 million aggregate principal amount of 0.75% convertible senior notes due 2032 (the notes) to persons...

$NEO Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.02 up 105.71% YoY
• Reported revenue of $201.66M up 11.21% YoY

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Neogenomics Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info